RAIsonance, Inc., formally launches its innovative mobile app: MyAdvocate LC/PCC.

RAIsonance is recruiting users to join its Air Quality Human Impact Program to track the impact of poor air quality on the human respiratory system

RAIsonance has released its Fall 2023 Workforce Wellness Risk Forecast Report, offering evidence-based insights into potential health risks for the upcoming season, aiding employers in preparing for and mitigating productivity disruptions from contagious illnesses in the...

RAIsonance’s Forced Cough Vocalization (FCV) Signature Analysis Technology is Designed to Diagnose Respiratory Illnesses Via a Cloud-Based Diagnostic Platform and a Mobile App User Interface 

MyAdvocate Product Tracks Progress Upon Quitting and Delivers a Personalized Biometric Score for Each User’s Respiratory Wellness Journey

MyAdvocate, AI Cough Analysis Technology to Help Young People Quit Harmful Smoking and Vaping Habit

RAIsonance Inc. announces the beta testing phase of its innovative, AI-powered tracker for sufferers of Long COVID. Part of the MyAdvocate line of Forced Cough Vocalization (FCV) wellness products, this platform was specially developed to track the unique and complex sym...

AI-Powered Innovation using Forced Cough Vocalization

RAIsonance, Inc., a group of Artificial Intelligence – Machine Learning (AI-ML) technology solutions companies, today announced the promotion of Paul McLenaghan to Chief Revenue Officer and the hiring of Kris Hopkins as Chief Product Officer.

RAIsonance, Inc., today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its AudibleHealth Dx Software as a Medical Device (SaMD). The device is designed to analyze a user’s Forced Coug...